Drug Profile
NK 292
Alternative Names: NK292Latest Information Update: 22 Feb 2010
Price :
$50
*
At a glance
- Originator Nippon Kayaku
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Breast cancer